News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,768 Results
Type
Article (43153)
Company Profile (297)
Press Release (677318)
Multimedia
Podcasts (80)
Webinars (12)
Section
Business (211259)
Career Advice (2114)
Deals (36763)
Drug Delivery (109)
Drug Development (83432)
Employer Resources (176)
FDA (16714)
Job Trends (15474)
News (357870)
Policy (34547)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2619)
Accelerated approval (5)
Adcomms (21)
Allergies (87)
Alliances (51644)
ALS (92)
Alzheimer's disease (1389)
Antibody-drug conjugate (ADC) (121)
Approvals (16711)
Artificial intelligence (258)
Autoimmune disease (22)
Automation (15)
Bankruptcy (371)
Best Places to Work (11804)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (189)
Bladder cancer (60)
Brain cancer (29)
Breast cancer (266)
Cancer (2132)
Cardiovascular disease (179)
Career advice (1769)
Career pathing (30)
CAR-T (148)
Cell therapy (413)
Cervical cancer (20)
Clinical research (67691)
Collaboration (817)
Compensation (514)
Complete response letters (26)
COVID-19 (2673)
CRISPR (43)
C-suite (230)
Cystic fibrosis (103)
Data (2071)
Decentralized trials (2)
Denatured (27)
Depression (42)
Diabetes (263)
Diagnostics (6449)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (111)
Drug shortages (28)
Duchenne muscular dystrophy (94)
Earnings (88311)
Editorial (40)
Employer branding (22)
Employer resources (150)
Events (115277)
Executive appointments (709)
FDA (17918)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (732)
Gene editing (108)
Generative AI (22)
Gene therapy (304)
GLP-1 (744)
Government (4801)
Grass and pollen (4)
Guidances (51)
Healthcare (19156)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (119)
Indications (27)
Infectious disease (2814)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (93)
Interviews (329)
IPO (16810)
IRA (47)
Job creations (4096)
Job search strategy (1511)
Kidney cancer (9)
Labor market (36)
Layoffs (492)
Leadership (17)
Legal (8476)
Liver cancer (74)
Lung cancer (305)
Lymphoma (142)
Machine learning (5)
Management (59)
Manufacturing (298)
MASH (64)
Medical device (13490)
Medtech (13495)
Mergers & acquisitions (20466)
Metabolic disorders (688)
Multiple sclerosis (75)
NASH (17)
Neurodegenerative disease (89)
Neuropsychiatric disorders (26)
Neuroscience (1919)
NextGen: Class of 2025 (6668)
Non-profit (4566)
Northern California (2547)
Now hiring (38)
Obesity (373)
Opinion (235)
Ovarian cancer (74)
Pain (90)
Pancreatic cancer (81)
Parkinson's disease (149)
Partnered (21)
Patents (229)
Patient recruitment (100)
Peanut (50)
People (59430)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20959)
Phase II (29746)
Phase III (22358)
Pipeline (1128)
Policy (145)
Postmarket research (2702)
Preclinical (8884)
Press Release (68)
Prostate cancer (101)
Psychedelics (31)
Radiopharmaceuticals (252)
Rare diseases (390)
Real estate (6294)
Recruiting (68)
Regulatory (23353)
Reports (46)
Research institute (2386)
Resumes & cover letters (362)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (73)
Series A (127)
Series B (82)
Service/supplier (13)
Sickle cell disease (55)
Southern California (2192)
Special edition (15)
Spinal muscular atrophy (154)
Sponsored (29)
Startups (3741)
State (2)
Stomach cancer (14)
Supply chain (67)
Tariffs (28)
The Weekly (51)
United States (22274)
Vaccines (694)
Venture capitalists (38)
Weight loss (254)
Women's health (34)
Worklife (15)
Date
Today (6)
Last 7 days (477)
Last 30 days (2357)
Last 365 days (33447)
2025 (9392)
2024 (35872)
2023 (40725)
2022 (51907)
2021 (56495)
2020 (55016)
2019 (47771)
2018 (36061)
2017 (33291)
2016 (32871)
2015 (38781)
2014 (32704)
2013 (27828)
2012 (29909)
2011 (30637)
2010 (28674)
Location
Africa (801)
Alabama (52)
Alaska (7)
Arizona (237)
Arkansas (14)
Asia (40846)
Australia (6558)
California (5820)
Canada (1964)
China (505)
Colorado (256)
Connecticut (263)
Delaware (137)
Europe (87550)
Florida (864)
Georgia (202)
Idaho (58)
Illinois (529)
India (27)
Indiana (312)
Iowa (9)
Japan (153)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (866)
Massachusetts (4400)
Michigan (217)
Minnesota (381)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1676)
New Mexico (29)
New York (1660)
North Carolina (960)
North Dakota (7)
Northern California (2547)
Ohio (194)
Oklahoma (14)
Oregon (38)
Pennsylvania (1319)
Puerto Rico (11)
Rhode Island (30)
South America (1175)
South Carolina (20)
South Dakota (1)
Southern California (2192)
Tennessee (100)
Texas (870)
Utah (173)
Virginia (143)
Washington D.C. (60)
Washington State (541)
West Virginia (3)
Wisconsin (53)
720,768 Results for "novartis pharmaceuticals canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Novartis Canada’s statement on CADTH draft recommendations for LEQVIO (inclisiran)
Novartis Pharmaceuticals Canada Inc. (Novartis Canada) is deeply disappointed with the draft recommendations of the Canadian Drug Expert Committee (CDEC) issued by the Canadian Agency for Drugs and Technologies in Health (CADTH) for LEQVIO® (inclisiran).
March 21, 2024
·
4 min read
Business
Novartis Canada and Clarius Mobile Health Challenge Standard of Care for Psoriatic Arthritis With New Partnership
Novartis Pharmaceuticals Canada Inc. is pleased to announce a partnership with Clarius Mobile Health as part of a dedicated effort to aid in early detection of psoriatic arthritis in Canada.
May 27, 2024
·
4 min read
Press Releases
Novartis receives Health Canada approval for Fabhalta® oral treatment for adult patients with PNH
February 14, 2025
·
8 min read
Spinal muscular atrophy
Novartis’ Intrathecal Zolgensma Effective in Older Children
After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.
March 19, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
April 9, 2025
·
5 min read
Manufacturing
Novartis Pledges $23B Boost to US Ops as Trump Intensifies Tariff Threats
Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The new facilities will include a biomedical research hub in California, two radioligand plants, and four manufacturing sites.
April 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris
April 10, 2025
·
7 min read
Press Releases
Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without Aura in Canada
April 16, 2025
·
8 min read
Rare diseases
Novartis’ Fabhalta Approved as First Therapy for Rare Kidney Disease
This is the third indication for Fabhalta after Novartis won FDA approval of the small molecule in paroxysmal nocturnal hemoglobinuria and primary immunoglobulin A nephropathy.
March 21, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Ferring Inc. Receives Health Canada Approval for REBYOTA® (fecal microbiota, live)
March 7, 2025
·
9 min read
1 of 72,077
Next
